Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PARENT.DRUGS vs IND. SWIFT - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PARENT.DRUGS IND. SWIFT PARENT.DRUGS/
IND. SWIFT
 
P/E (TTM) x -0.1 2.0 - View Chart
P/BV x - - - View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 PARENT.DRUGS   IND. SWIFT
EQUITY SHARE DATA
    PARENT.DRUGS
Mar-21
IND. SWIFT
Mar-24
PARENT.DRUGS/
IND. SWIFT
5-Yr Chart
Click to enlarge
High Rs324 13.1%   
Low Rs37 36.6%   
Sales per share (Unadj.) Rs4.192.7 4.4%  
Earnings per share (Unadj.) Rs-40.82.6 -1,553.4%  
Cash flow per share (Unadj.) Rs-35.07.6 -458.6%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs-229.0-127.6 179.5%  
Shares outstanding (eoy) m29.8254.16 55.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.70.2 417.7%   
Avg P/E ratio x-0.16.0 -1.2%  
P/CF ratio (eoy) x-0.12.1 -4.0%  
Price / Book Value ratio x0-0.1 10.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m86850 10.1%   
No. of employees `000NANA-   
Total wages/salary Rs m145729 19.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m1225,022 2.4%  
Other income Rs m1580 0.1%   
Total revenues Rs m1225,602 2.2%   
Gross profit Rs m-118485 -24.3%  
Depreciation Rs m173271 63.9%   
Interest Rs m1,254629 199.3%   
Profit before tax Rs m-1,545165 -938.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-32822 -1,467.7%   
Profit after tax Rs m-1,217142 -855.3%  
Gross profit margin %-96.89.7 -1,001.6%  
Effective tax rate %21.213.6 156.4%   
Net profit margin %-1,000.32.8 -35,301.3%  
BALANCE SHEET DATA
Current assets Rs m6813,418 19.9%   
Current liabilities Rs m11,4363,204 357.0%   
Net working cap to sales %-8,839.34.3 -207,202.5%  
Current ratio x0.11.1 5.6%  
Inventory Days Days37556 666.0%  
Debtors Days Days01,106 0.0%  
Net fixed assets Rs m3,3433,127 106.9%   
Share capital Rs m298108 275.2%   
"Free" reserves Rs m-7,127-7,017 101.6%   
Net worth Rs m-6,829-6,908 98.8%   
Long term debt Rs m1,07210,095 10.6%   
Total assets Rs m4,0246,545 61.5%  
Interest coverage x-0.21.3 -18.3%   
Debt to equity ratio x-0.2-1.5 10.7%  
Sales to assets ratio x00.8 3.9%   
Return on assets %0.911.8 7.8%  
Return on equity %17.8-2.1 -865.2%  
Return on capital %5.024.9 20.2%  
Exports to sales %075.6 0.0%   
Imports to sales %04.2 0.0%   
Exports (fob) Rs mNA3,796 0.0%   
Imports (cif) Rs mNA211 0.0%   
Fx inflow Rs m03,893 0.0%   
Fx outflow Rs m0289 0.0%   
Net fx Rs m03,605 0.0%   
CASH FLOW
From Operations Rs m1,253153 820.0%  
From Investments Rs m1766 0.1%  
From Financial Activity Rs m-1,254-421 298.1%  
Net Cashflow Rs m-1498 -0.1%  

Share Holding

Indian Promoters % 73.3 55.6 131.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 26.7 44.4 60.1%  
Shareholders   7,129 18,028 39.5%  
Pledged promoter(s) holding % 94.5 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PARENT.DRUGS With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on PARENT.DRUGS vs IND. SWIFT

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

PARENT.DRUGS vs IND. SWIFT Share Price Performance

Period PARENT.DRUGS IND. SWIFT S&P BSE HEALTHCARE
1-Day 4.63% -1.76% 0.97%
1-Month 9.71% 7.95% 1.29%
1-Year -19.48% 19.57% 46.30%
3-Year CAGR 8.97% 15.72% 19.65%
5-Year CAGR -19.84% 42.01% 26.13%

* Compound Annual Growth Rate

Here are more details on the PARENT.DRUGS share price and the IND. SWIFT share price.

Moving on to shareholding structures...

The promoters of PARENT.DRUGS hold a 73.3% stake in the company. In case of IND. SWIFT the stake stands at 55.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of PARENT.DRUGS and the shareholding pattern of IND. SWIFT.

Finally, a word on dividends...

In the most recent financial year, PARENT.DRUGS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

IND. SWIFT paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of PARENT.DRUGS, and the dividend history of IND. SWIFT.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 993 Points | Nifty Above 24,200 | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 993 Points | Nifty Above 24,200 | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.